Kaplan–Meier survival (Fig. 1B) test showed that ARID1A protein expression in Ov-CCA was not associated with prognosis (HR = 0.953, 95% CI [0.636–1.427]). This evidence concerns the gene ARID1A and cholangiocarcinoma.